Accubiotech Co.,Ltd

Accubiotech Co.,Ltd AccuBioTech Co., Ltd. is a biotech company specializing in developing, manufacturing and distribution of in vitro rapid diagnostic tests and Lab Equipment.

AccuBioTech has established and applied a quality management system for medical devices according to the requirements specified in EN ISO 13485:2016. Over 50 of our products are CE marked.

Drug abuse screening plays a critical role in workplace safety, rehabilitation programs, and law enforcement.AccuBioTech...
03/08/2026

Drug abuse screening plays a critical role in workplace safety, rehabilitation programs, and law enforcement.
AccuBioTech® Drug of Abuse Tests provide rapid and reliable screening solutions for various substances, helping professionals make informed decisions efficiently.
✓ Multiple drug panels available
✓ Urine & saliva specimen options
✓ Rapid results within minutes
✓ Easy-to-use test formats
From workplace compliance to public safety, AccuBioTech supports accurate screening when it matters most.

Built for Modern Laboratories.Rapid testing is evolving from visual interpretation to digital confidence.The Accu-Tell® ...
30/07/2026

Built for Modern Laboratories.
Rapid testing is evolving from visual interpretation to digital confidence.
The Accu-Tell® RDP-700 Digital Lateral Flow Reader is designed to help laboratories achieve standardized results, smarter workflows, and improved data management.
From sample identification to final reporting, the RDP-700 simplifies every step:
✔ QR code sample identification
✔ Objective optical interpretation
✔ Automatic result analysis
✔ PDF & Excel export
✔ Bluetooth printing
✔ LIS connectivity
Beyond a reader, the RDP-700 provides a scalable digital platform supporting multiple rapid diagnostic applications:
🦠 Infectious Disease
💊 Drugs of Abuse
👩 Women's Health
❤️ Cardiology
🎗 Oncology
One Reader. Multiple Applications.
Discover a smarter way to manage lateral flow diagnostics.

🌍 World Hepatitis Day 2026Break the Silence. Expand Hepatitis Screening.Hepatitis remains a global health challenge, and...
28/07/2026

🌍 World Hepatitis Day 2026
Break the Silence. Expand Hepatitis Screening.
Hepatitis remains a global health challenge, and many infections may go unnoticed without timely screening. Early detection plays an essential role in supporting healthcare decisions, improving disease management, and strengthening public health initiatives.
On World Hepatitis Day 2026, AccuBioTech highlights the importance of accessible and reliable hepatitis testing solutions that help healthcare professionals identify risks earlier and support better health outcomes.
Through the Accu-Tell® Comprehensive Hepatitis Rapid Testing Portfolio, we provide flexible diagnostic solutions covering:
🔹 Hepatitis A (HAV)
Antibody detection solutions supporting Hepatitis A screening.
🔹 Hepatitis B (HBV)
Comprehensive serology testing solutions covering key HBV markers.
🔹 Hepatitis C (HCV)
Accessible Anti-HCV screening solutions for diverse healthcare settings.
🔹 Multi-Marker Combo Testing
Integrated screening solutions supporting efficient infectious disease testing.
Designed for real-world healthcare needs, Accu-Tell® solutions offer:
✓ Comprehensive HAV, HBV & HCV coverage
✓ Flexible strip and cassette formats
✓ Multiple sample options
✓ Reliable rapid diagnostic performance
From local clinics to global healthcare programs, AccuBioTech remains committed to making reliable diagnostics more accessible worldwide.
Together, let’s promote awareness, encourage early screening, and support a healthier future.
Accu-Tell® — Accurate. Reliable. Accessible.

Visual interpretation has long been part of lateral flow testing—but it also introduces variability.The Accu-Tell® RDP-7...
23/07/2026

Visual interpretation has long been part of lateral flow testing—but it also introduces variability.
The Accu-Tell® RDP-700 replaces subjective judgement with standardized digital interpretation, helping laboratories improve consistency, efficiency, and traceability.
✔ Objective optical analysis
✔ QR-based identification
✔ Automatic result interpretation
✔ LIS connectivity
✔ Digital reporting
Digital reading isn't just faster.
It's smarter.

16/07/2026

🧬 AccuBioTech is heading to ADLM 2026!
We're excited to announce that we will be exhibiting at the ADLM 2026 Clinical Lab Expo (formerly AACC) — the premier global event for laboratory medicine.
📅 July 28–30, 2026
📍 Anaheim Convention Center, California
🎯 Booth #2077
Come meet our 3D digital avatar and discover our latest rapid diagnostic solutions across:
Infectious Diseases
Drugs of Abuse Testing
Fertility Testing
Urine Analysis
And more
With 25+ years of global expertise and a portfolio of 280+ IVD tests trusted by healthcare professionals in 70+ countries, AccuBioTech is your reliable partner in precision diagnostics.
We'd love to connect, share our innovations, and explore partnership opportunities. Stop by Booth #2077 — let's talk about how we can support your laboratory needs.
🔗 Learn more: [Insert Website/Meeting Link]

Why Visit AccuBioTech at ADLM 2026?Join us at Booth  #2077 to discover our latest rapid diagnostic solutions designed fo...
13/07/2026

Why Visit AccuBioTech at ADLM 2026?
Join us at Booth #2077 to discover our latest rapid diagnostic solutions designed for clinical laboratories, healthcare providers, workplace testing programs, and distribution partners worldwide.
Featured Product Categories:
🔹 Infectious Disease Testing
🔹 Drugs of Abuse Testing
🔹 Fertility & Women's Health Testing
🔹 Urinalysis Solutions
🔹 Rapid Diagnostic Analyzers
Our team will also be available to discuss:
✔ OEM & ODM Manufacturing
✔ Private Label Solutions
✔ Global Distribution Partnerships
✔ Customized Diagnostic Solutions
Whether you are looking to expand your product portfolio, strengthen your supply chain, or explore new business opportunities, we look forward to meeting you.
📅 July 28–30, 2026
📍 Anaheim, California, USA
🏢 Booth #2077
Visit AccuBioTech at ADLM 2026 and discover how our reliable, high-quality diagnostic solutions can support your business growth.

🏆 Independently Verified. Public Health Ready.We are proud to announce that both the Accu-Tell HIV 1/2 Rapid Test and Ac...
10/07/2026

🏆 Independently Verified. Public Health Ready.
We are proud to announce that both the Accu-Tell HIV 1/2 Rapid Test and Accu-Tell Syphilis Rapid Test successfully met the performance requirements of Guatemala’s National Rapid Test Verification Program conducted by the Directorate of the National Health Laboratory (DLNS).
🔬 Verification conducted using 350 well-characterized clinical samples
✅ Accu-Tell HIV 1/2 Rapid Test
• 99.44% Sensitivity
• 98.84% Specificity
• Kappa 0.98
✅ Accu-Tell Syphilis Rapid Test
• 97.14% Sensitivity
• 97.14% Specificity
• 100% Positive Predictive Value (PPV)
Designed for real-world screening environments:
✔ Only 30 μL sample required
✔ Whole blood, serum, or plasma compatible
✔ Rapid and easy-to-read results
✔ Suitable for laboratories, public health programs, NGOs, and point-of-care testing
At AccuBioTech, we are committed to delivering reliable diagnostic solutions that support earlier detection, better patient outcomes, and stronger public health systems worldwide.

🌎 We’re heading to ADLM 2026!AccuBioTech is excited to announce our participation in ADLM 2026, one of the world’s leadi...
06/07/2026

🌎 We’re heading to ADLM 2026!
AccuBioTech is excited to announce our participation in ADLM 2026, one of the world’s leading events for laboratory medicine and diagnostics.
📅 July 28–30, 2026
📍 Anaheim, CA, USA
🏢 Booth #2077
Visit our booth to explore a comprehensive portfolio of rapid diagnostic solutions, including:
✔ Infectious Disease Tests
✔ Drugs of Abuse Tests
✔ Fertility Tests
✔ Cardiac Tests
✔ Tumor Marker Tests
✔ Urine Analysis Tests
✔ Uncut Sheet
Since 2000, AccuBioTech Co., Ltd. has been committed to supporting healthcare professionals worldwide with reliable, accessible and cost-effective diagnostic solutions.
We look forward to connecting with distributors, laboratory professionals and industry partners from around the world to explore new collaboration opportunities.
📩 Schedule a meeting with our team today.

The Hidden Risk in Drug TestingA negative drug test result doesn't always mean the sample is valid.In workplace screenin...
02/07/2026

The Hidden Risk in Drug Testing
A negative drug test result doesn't always mean the sample is valid.
In workplace screening and laboratory testing, specimen adulteration remains a critical challenge.
Common issues may include:
▪ Dilution
▪ Synthetic urine
▪ Sample substitution
▪ Chemical adulterants
That's why many organizations are looking beyond drug detection alone and placing greater emphasis on specimen validity verification.
AccuBioTech's Multi-Drug Cup Series offers flexible configurations combining:
✔ Drug Screening
✔ Alcohol Detection
✔ Specimen Validity Testing
✔ Lockable Collection Options
Because reliable screening starts with a reliable specimen.
What measures does your organization use to help ensure sample integrity?

Address

Beijing
101300

Alerts

Be the first to know and let us send you an email when Accubiotech Co.,Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Accubiotech Co.,Ltd:

Shortcuts

Share